Clinical Trial Update: EXoPERT EMERALD Clinical Study

View source ↗

Summary

Clinical trial update indicates the EXoPERT EMERALD study is currently recruiting across multiple cancer indications, including breast, colorectal, pancreatic, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Snippet

Sponsor: EXoPERT | Conditions: Breast Cancer, Colon Cancer | Status: RECRUITING